Diagnos Stock Performance
| DGNOF Stock | USD 0.25 0.01 3.85% |
On a scale of 0 to 100, DIAGNOS holds a performance score of 4. The firm owns a Beta (Systematic Risk) of 0.21, which means not very significant fluctuations relative to the market. As returns on the market increase, DIAGNOS's returns are expected to increase less than the market. However, during the bear market, the loss of holding DIAGNOS is expected to be smaller as well. Please check DIAGNOS's value at risk, rate of daily change, and the relationship between the total risk alpha and expected short fall , to make a quick decision on whether DIAGNOS's current price history will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in DIAGNOS are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, DIAGNOS reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 359.4 K | |
| Total Cashflows From Investing Activities | 503.5 K | |
| Free Cash Flow | -2.1 M |
DIAGNOS |
DIAGNOS Relative Risk vs. Return Landscape
If you would invest 23.00 in DIAGNOS on November 3, 2024 and sell it today you would earn a total of 2.00 from holding DIAGNOS or generate 8.7% return on investment over 90 days. DIAGNOS is currently producing 0.2278% returns and takes up 4.3535% volatility of returns over 90 trading days. Put another way, 38% of traded otc stocks are less volatile than DIAGNOS, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
DIAGNOS Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DIAGNOS's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as DIAGNOS, and traders can use it to determine the average amount a DIAGNOS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0523
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DGNOF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.35 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average DIAGNOS is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DIAGNOS by adding it to a well-diversified portfolio.
DIAGNOS Fundamentals Growth
DIAGNOS OTC Stock prices reflect investors' perceptions of the future prospects and financial health of DIAGNOS, and DIAGNOS fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DIAGNOS OTC Stock performance.
| Return On Equity | -24.52 | |||
| Return On Asset | -1.21 | |||
| Operating Margin | (4.06) % | |||
| Current Valuation | 12.4 M | |||
| Shares Outstanding | 69.47 M | |||
| Price To Earning | (4.08) X | |||
| Price To Book | 55.55 X | |||
| Price To Sales | 16.90 X | |||
| Revenue | 438.83 K | |||
| EBITDA | (2.45 M) | |||
| Cash And Equivalents | 252.14 K | |||
| Total Debt | 831.58 K | |||
| Debt To Equity | 2.45 % | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (2.04 M) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 1.54 M | |||
About DIAGNOS Performance
By analyzing DIAGNOS's fundamental ratios, stakeholders can gain valuable insights into DIAGNOS's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DIAGNOS has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DIAGNOS has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company was founded in 1998 and is headquartered in Brossard, Canada. Diagnos operates under Health Information Services classification in the United States and is traded on OTC Exchange.Things to note about DIAGNOS performance evaluation
Checking the ongoing alerts about DIAGNOS for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for DIAGNOS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DIAGNOS has some characteristics of a very speculative penny stock | |
| DIAGNOS had very high historical volatility over the last 90 days | |
| DIAGNOS has accumulated 831.58 K in total debt with debt to equity ratio (D/E) of 2.45, implying the company greatly relies on financing operations through barrowing. DIAGNOS has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist DIAGNOS until it has trouble settling it off, either with new capital or with free cash flow. So, DIAGNOS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like DIAGNOS sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for DIAGNOS to invest in growth at high rates of return. When we think about DIAGNOS's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 438.83 K. Net Loss for the year was (2.61 M) with loss before overhead, payroll, taxes, and interest of (418.3 K). | |
| DIAGNOS has accumulated about 252.14 K in cash with (2.04 M) of positive cash flow from operations. | |
| Roughly 16.0% of DIAGNOS shares are held by company insiders |
- Analyzing DIAGNOS's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DIAGNOS's stock is overvalued or undervalued compared to its peers.
- Examining DIAGNOS's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DIAGNOS's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DIAGNOS's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of DIAGNOS's otc stock. These opinions can provide insight into DIAGNOS's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DIAGNOS OTC Stock analysis
When running DIAGNOS's price analysis, check to measure DIAGNOS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DIAGNOS is operating at the current time. Most of DIAGNOS's value examination focuses on studying past and present price action to predict the probability of DIAGNOS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DIAGNOS's price. Additionally, you may evaluate how the addition of DIAGNOS to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |